Use of [methyl-3H]Yohimbine as a radioligand for alpha-2 adrenoreceptors on intact platelets. Comparison with dihydroergocryptine.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000032:analysis*; D001792:Blood Platelets / Q000378:metabolism*; D003000:Clonidine / Q000031:analogs & derivatives / Q000494:pharmacology; D004088:Dihydroergotoxine / Q000032:analysis; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D010646:Phentolamine / Q000494:pharmacology; D011869:Radioligand Assay; D015016:Yohimbine / Q000032:analysis*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D004088:Dihydroergotoxine; D015016:Yohimbine; C016986:apraclonidine; D003000:Clonidine; D004837:Epinephrine; D010646:Phentolamine